These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26419637)

  • 1. New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
    Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
    Org Biomol Chem; 2015 Dec; 13(46):11302-14. PubMed ID: 26419637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
    Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of C-functionalized TE1PA and comparison with its analogues. An example of bioconjugation on 9E7.4 mAb for multiple myeloma
    Le Bihan T; Navarro AS; Le Bris N; Le Saëc P; Gouard S; Haddad F; Gestin JF; Chérel M; Faivre-Chauvet A; Tripier R
    Org Biomol Chem; 2018 Jun; 16(23):4261-4271. PubMed ID: 29701218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TE1PA as Innovating Chelator for
    Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A
    Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
    Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL
    Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators.
    David T; Hlinová V; Kubíček V; Bergmann R; Striese F; Berndt N; Szöllősi D; Kovács T; Máthé D; Bachmann M; Pietzsch HJ; Hermann P
    J Med Chem; 2018 Oct; 61(19):8774-8796. PubMed ID: 30180567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New bifunctional chelator for 64Cu-immuno-positron emission tomography.
    Pandya DN; Bhatt N; Dale AV; Kim JY; Lee H; Ha YS; Lee JE; An GI; Yoo J
    Bioconjug Chem; 2013 Aug; 24(8):1356-66. PubMed ID: 23883075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
    Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
    Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full control of the regiospecific N-functionalization of C-functionalized cyclam bisaminal derivatives and application to the synthesis of their TETA, TE2A, and CB-TE2A analogues.
    Camus N; Halime Z; Le Bris N; Bernard H; Platas-Iglesias C; Tripier R
    J Org Chem; 2014 Mar; 79(5):1885-99. PubMed ID: 24552189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling.
    Boswell CA; Regino CA; Baidoo KE; Wong KJ; Bumb A; Xu H; Milenic DE; Kelley JA; Lai CC; Brechbiel MW
    Bioconjug Chem; 2008 Jul; 19(7):1476-84. PubMed ID: 18597510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
    Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
    J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.
    Fani M; Del Pozzo L; Abiraj K; Mansi R; Tamma ML; Cescato R; Waser B; Weber WA; Reubi JC; Maecke HR
    J Nucl Med; 2011 Jul; 52(7):1110-8. PubMed ID: 21680701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.
    Paterson BM; Buncic G; McInnes LE; Roselt P; Cullinane C; Binns DS; Jeffery CM; Price RI; Hicks RJ; Donnelly PS
    Dalton Trans; 2015 Mar; 44(11):4901-9. PubMed ID: 25351329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
    Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
    Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
    Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
    Org Biomol Chem; 2016 Apr; 14(15):3838. PubMed ID: 27007016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents.
    Sprague JE; Peng Y; Fiamengo AL; Woodin KS; Southwick EA; Weisman GR; Wong EH; Golen JA; Rheingold AL; Anderson CJ
    J Med Chem; 2007 May; 50(10):2527-35. PubMed ID: 17458949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
    Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
    Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.
    Litau S; Seibold U; Vall-Sagarra A; Fricker G; Wängler B; Wängler C
    ChemMedChem; 2015 Jul; 10(7):1200-8. PubMed ID: 26011290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
    Guo Y; Ferdani R; Anderson CJ
    Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
    Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
    Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.